Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) jumped 20.7% in the afternoon session after the company reported strong first quarter 2025 results which
Author: techrossm
I’d Invest $10,000 in This Single Stock for the Next 20 Years
In the last five years, the company has seen its revenue grow by 39% to $684 million and its operating cash flow increase by
Wealth Management Teams Are Getting Bigger. The Best Ones Are Also Getting Better.
Large financial advisor teams often can offer more services and investment strategies than their smaller peers. But sometimes being too big can backfire.
When Experts Say ‘The Stock Market Is Not the Economy,’ What Do They Mean?
When experts claim “the stock market isn’t the economy,” they’re highlighting a crucial disconnect between Wall Street and Main Street. With record market participation
VisionPoint Advisory Group, Navitas Wealth Advisors Merge to Create $3.7 Billion Powerhouse
Plus: Comerica Bank contributes $250,000 during National Small Business Week and Garages of America moves forward with its expansion in Allen.
Why BofA says more trade deals can’t keep the stock market rally alive
The S&P 500 has rallied sharply since April lows, but investors should be prepared for the gains to fade as more trade deals are
Dow and S&P 500 Up Slightly in Afternoon Trading
The stock market was about as mixed as it gets on Friday. The S&P 500 and Nasdaq Composite were both up slightly and trading
Best Practices For Dividend Investing
These companies are mature, with slower earnings growth, and they often choose to return a larger portion of profits to shareholders. Click to read.
Is Snap Inc. (SNAP) the Best Low Priced Stock to Invest in For the Long Term?
We recently published a list of 10 Best Low Priced Stocks to Invest in For the Long Term. In this article, we are going
60-40 portfolio is dead, but it’s not the bond market that killed it, says financial planning icon Ric Edelman
The traditional 60-40 stock and bond portfolio for retirement financial security is dead, says Ric Edelman, but the reason is breakthroughs in human longevity.